-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Foghorn Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q2 2024.
- Foghorn Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 51.6M shares, a 23.3% increase year-over-year.
- Foghorn Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 42M shares, a 0.92% increase from 2022.
- Foghorn Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 41.6M shares, a 11.9% increase from 2021.
- Foghorn Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 37.2M shares, a 236% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)